Advanced Therapies Investment Summit
10th of September, 9 – 11.30am | Palácio Estoril Hotel, Golf & Wellness, Cascais
The industry signals major investment opportunities arising from European biotech’s pioneering advanced therapies, rare disease treatments, and strategic acquisitions by big pharma seeking innovation pipelines. The Advanced Therapies Investment Summit offers an unparalleled opportunity to gain a competitive edge in one of biotech’s hottest sectors. This exclusive half-day summit will provide you with the strategic insights, investor perspectives, and networking opportunities to drive investment and commercialization success in the dynamic European ATMP sector.
Don’t miss this opportunity to get in on the ground floor of Europe’s biotech boom.
With participation from:
Key themes this year:
Navigating the European ATMP Landscape
Broad discussions surrounding the current state of the advanced therapies market in Europe, strategic roadmaps for ATMP commercialization, and the unique challenges and opportunities faced by European therapeutic developers and investors in this space.
Funding the ATMP Journey – From Seed to Commercial Success
Specific insights delving into the financing considerations for advanced therapy medicinal products (ATMPs), including assessing risk tolerance, capital expenditure, and allocation strategies across different stages of development, from early-stage funding to commercialization.
Investor Perspectives on ATMP Investment Strategies
Provides a direct platform for attendees to engage with investors actively funding ATMP companies, allowing for candid discussions and insights on investment strategies, risk assessment, and investor expectations in the rapidly evolving ATMP sector.
This is an add-on opportunity for #ATE24 ticket holders. To obtain yours, simply register now!
AGENDA
